Table 4.
Publication | Model | Change with SAH | Intervention |
---|---|---|---|
Yan et al.67 | Rat/EP | ↓ Occludin (WB, IHC) 24 h | Pifithrin-α (p53 inhibition) |
Simard et al.78 | Rat/EP | Occludin redistribution IHC | Glibenclamide |
Sozen et al.71 | Mouse/EP | ↓ ZO-1 (WB) 24 h | IL-1β converting enzyme inhibition |
Hasegawa et al.66 | Rat/EP | ↓ Occludin (WB) 24 h | Na orthovanadate |
Fujii et al.62 | Rat/EP | ↓ Occludin/ZO-1 (WB) 24 h | Hydroxyfasudil (ROCK inhibition) |
Wang et al.75 | Rat/BI | ↓ Occludin/ZO-1 (WB) 48 h | HIF-1α, MMPs, aquaporin-4 |
Chen et al.58 | Rat/EP | ↓ occludin/ZO-1 (WB/IHC) 24 h | c-Jun N-terminal kinase inhibition |
Altay et al.69 | Mice/EP | ↓ Claudin-5/ZO-1/JAM-A/VE-cadherin (WB) 24 h | Isoflurane |
Chen et al.59 | Rat/EP | ↓ Occludin/ZO-1/claudin-5 (WB) 24 h | Melatonin |
Fujii et al.63 | Rat/EP | ↓ ZO-1 (WB) 24 h | Cannabanoid-2 receptor |
Li et al.34 | Rat/EP | ↓ Occludin/ZO-1 ↔claudin-5 (WB, IHC) 0.5 – 168 h | None |
Chen et al.60 | Rat/EP | ↓ Occludin/ZO-1/claudin-5/VE-cadherin (WB, IHC) 24 h | Norrin/frizzled-4 |
Xu et al.72 | Mice/EP | ↓ ZO-1/VE-cadherin (WB, IHC) 24 h | Thrombomodulin |
Zhou et al.76 | Rat/BI | ↓ ZO-1 (WB) 24 h | Progranulin |
Zhou et al.77 | Rat/BI | ↓ ZO-1 (WB) 24 h | Fisetin (flavonoid) |
Chen et al.64 | Rat/EP | ↓ Claudin-5/occludin (WB) 24 h | PARP inhibition |
Fujimoto et al.192 | Mice/EP | ↓ ZO-1 (WB) 24 h | Tenascin-C |
Fang et al.65 | Rat/EP | ↓ Claudin-5/occludin (WB) 24 h | Ethyl pyruvate |
Ying et al.68 | Rat/EP | ↓ Claudin-5/occludin (WB) 24 h | Valproic acid |
Liu et al.74 | Rat/BI | ↓ Occludin/ZO-1 | Matrine (alkaloid) |
Pang et al.70 | Mice/EP | ↓ Occludin/ZO-1/claudin-5 (WB) 48 h | Apolipoprotein E |
Yuan et al.73 | Mice/EP | ↓ Occludin/ZO-1 (WB) 24 h | Curcumin |
Fan et al.61 | Rat/EP | ↓ Claudin-5/ZO-1 (WB) 24 h | Eph receptor-A4/Fasudil (ROCK inhibition) |
: decrease, ↔: no change.
EP: endovascular perforation; BI: blood injection; WB: Western blot; IHC: immunohistochemistry; HIF-1α: hypoxia inducible factor-1α; MMPs: matrix metalloproteinases; PARP: Poly (ADP-ribose) polymerase; ROCK: RhoA kinase.